Human and animal studies have suggested that decreased adiponectin levels are an independent risk factor for cardiovascular diseases [48] and act as an emerging biomarker of non-alcoholic fatty liver disease [49]. The gene discussed is ADIPOQ; the disease is cardiovascular disorder.